A Delphi study on the clinical management of age-related macular degeneration
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Delphi study on the clinical management of age-related macular degeneration
Authors
Keywords
-
Journal
INTERNATIONAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-12
DOI
10.1007/s10792-021-02177-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
- (2020) Ashish Sharma et al. EYE
- Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease
- (2020) Peter J. Kertes et al. JAMA Ophthalmology
- Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
- (2020) María Isabel López Gálvez et al. ACTA OPHTHALMOLOGICA
- Application of Automated Quantification of Fluid Volumes to Anti–VEGF Therapy of Neovascular Age-Related Macular Degeneration
- (2020) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors
- (2020) Jakob Siedlecki et al. Scientific Reports
- Current Perspective on Age-Related Macular Degeneration
- (2020) Usha Chakravarthy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration
- (2020) et al. OPHTHALMOLOGE
- Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration
- (2020) Alessandro Arrigo et al. Translational Vision Science & Technology
- OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2019) Cláudia Farinha et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid
- (2019) Antony J. Wightman et al. Translational Vision Science & Technology
- Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
- (2018) SriniVas R. Sadda et al. OPHTHALMOLOGY
- Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen
- (2018) Robyn H. Guymer et al. OPHTHALMOLOGY
- A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab
- (2017) S R Rufai et al. EYE
- Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
- (2017) Paolo Lanzetta et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab
- (2017) Nizar S. Abdelfattah et al. OPHTHALMOLOGY
- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
- (2017) Pravin U. Dugel et al. OPHTHALMOLOGY
- Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
- (2017) Juan E. Grunwald et al. OPHTHALMOLOGY
- PREDICTORS OF ONE-YEAR VISUAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2017) Laurent Kodjikian et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2017) Petra Arendt et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab
- (2017) Lucia Gonzalez-Buendia et al. BMC Ophthalmology
- The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
- (2017) Tsukasa Hanemoto et al. PLoS One
- Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
- (2016) Frank G. Holz et al. OPHTHALMOLOGY
- Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials
- (2016) Sumit Sharma et al. OPHTHALMOLOGY
- The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
- (2016) Jennifer J. Arnold et al. BMC Ophthalmology
- Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration
- (2015) Jennifer J. Arnold et al. OPHTHALMOLOGY
- Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
- (2015) Karina Berg et al. OPHTHALMOLOGY
- Pigment Epithelial Detachment Followed by Retinal Cystoid Degeneration Leads to Vision Loss in Treatment of Neovascular Age-Related Macular Degeneration
- (2015) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
- (2015) Alfredo García-Layana et al. Journal of Ophthalmology
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Morphologic Parameters Relevant for Visual Outcome During Anti-Angiogenic Therapy of Neovascular Age-Related Macular Degeneration
- (2014) Christian Simader et al. OPHTHALMOLOGY
- Mechanisms of age-related macular degeneration and therapeutic opportunities
- (2013) Menno van Lookeren Campagne et al. JOURNAL OF PATHOLOGY
- Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Mechanisms of Age-Related Macular Degeneration
- (2012) Jayakrishna Ambati et al. NEURON
- Predictors of AMD Treatment Response
- (2012) Sanjeewa S. Wickremasinghe et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started